{"entity":{"id":"rejuv-life-employment-rights-us","kind":"technology","name":"Employment rights with cancer in the United States","aka":[],"tldr":"Federal regulation states that \"cancer substantially limits normal cell growth\", and the statute counts an impairment in remission if it would substantially limit a major life activity when active. The Americans with Disabilities Act reaches employers with 15 or more employees; unpaid job-protected leave under the Family and Medical Leave Act is 12 workweeks a year.","summary":"The statutory chain, read from the United States Code and the Code of Federal Regulations rather than from a summary.\n\nSection 12102(1) of title 42 defines disability as a physical or mental impairment that substantially limits one or more major life activities, a record of such an impairment, or being regarded as having one. Section 12102(2)(B), added by the Americans with Disabilities Act Amendments Act of 2008, provides that \"a major life activity also includes the operation of a major bodily function, including but not limited to, functions of the immune system, normal cell growth, digestive, bowel, bladder, neurological, brain, respiratory, circulatory, endocrine, and reproductive functions\". Section 12102(4)(A) directs that the definition \"shall be construed in favor of broad coverage\", and section 12102(4)(D) provides that \"An impairment that is episodic or in remission is a disability if it would substantially limit a major life activity when active\". Section 12102(4)(E) requires the assessment to be made without regard to the ameliorative effects of mitigating measures such as medication.\n\nThe regulation closes the loop explicitly. The Equal Employment Opportunity Commission's rule at 29 CFR 1630.2(j)(3)(iii) lists impairments for which the individualised assessment \"should be particularly simple and straightforward\" and states that it \"should easily be concluded\" that, among others, \"cancer substantially limits normal cell growth\".\n\nWho is covered. Section 12111(5)(A) defines an employer as \"a person engaged in an industry affecting commerce who has 15 or more employees for each working day in each of 20 or more calendar weeks in the current or preceding calendar year\". Smaller employers are outside the federal Act, although many states have their own laws with lower thresholds; OnCo has not surveyed those and does not state them here.\n\nWhat coverage gives. Protection from discrimination in hiring, firing, pay, promotion and terms, and a right to reasonable accommodation unless it would impose undue hardship on the employer. Typical accommodations are modified schedules, leave for treatment, telework, reassignment to a vacant position and physical changes to a workstation.\n\nLeave. The Family and Medical Leave Act is separate and narrower. Its fact sheet from the Department of Labor sets out the eligibility rules: an employee is eligible if they have worked for a covered employer for at least 12 months, have at least 1,250 hours of service in the 12 months before the leave starts, and work at a location where the employer has at least 50 employees within 75 miles. Covered employers include private-sector employers with 50 or more employees in 20 or more workweeks in the current or previous calendar year, public agencies regardless of size, and local educational agencies regardless of size. Eligible employees may take up to 12 workweeks of leave in a 12-month period for a serious health condition that makes them unable to work, or to care for a child, spouse or parent with a serious health condition, and up to 26 workweeks of military caregiver leave. The leave \"may be unpaid or used at the same time as employer-provided paid leave\", group health benefits continue under the same conditions, and \"Employees must be restored to the same or virtually identical position when they return to work\". Leave can be taken in blocks of hours rather than whole weeks where the employer's schedule allows, which is what makes a chemotherapy cycle workable.\n\nThe gap between the two. A person with cancer at a firm of 20 people is protected from discrimination by the Americans with Disabilities Act and has no entitlement to job-protected leave under the Family and Medical Leave Act, because that statute's threshold is 50 employees within 75 miles. A person at a firm of 10 has neither. That is the structural reason the financial consequences of cancer in the United States fall where they do, and it is why the record on money after treatment in this front carries the bankruptcy data.\n\nWhat OnCo did not verify in this round and therefore does not state: the rules on continuing health coverage after employment ends, the Social Security disability process and its Compassionate Allowances list, and state-level employment and paid family leave laws, each of which materially changes the picture and none of which was read from a primary source here.","status":"standard-of-care","asOf":"2026-10-02","wikipedia":"https://en.wikipedia.org/wiki/Americans_with_Disabilities_Act_of_1990","links":[{"label":"42 U.S.C. 12102: definition of disability (Legal Information Institute)","url":"https://www.law.cornell.edu/uscode/text/42/12102"},{"label":"42 U.S.C. 12111: definitions, including employer (Legal Information Institute)","url":"https://www.law.cornell.edu/uscode/text/42/12111"},{"label":"29 CFR 1630.2: ADA regulations, definitions (eCFR)","url":"https://www.ecfr.gov/current/title-29/subtitle-B/chapter-XIV/part-1630/section-1630.2"},{"label":"US Department of Labor Fact Sheet #28: the Family and Medical Leave Act","url":"https://www.dol.gov/agencies/whd/fact-sheets/28-fmla"}],"tags":["rejuvenation","survivorship","psychosocial","policy"],"related":["idea-acc-return-to-work-rehabilitation","idea-cost-financial-toxicity-screening"],"cancers":["breast-hr-positive","colorectal","prostate","nsclc","multiple-myeloma"],"sections":["rejuvenation","supportive-care"],"technologies":["rejuv-life-return-to-work","rejuv-life-money-after-treatment","rejuv-life-employment-rights-uk","financial-navigation","survivorship-care-plan"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["financial-toxicity","quality-of-life"],"trials":[],"people":[],"bottlenecks":["b-survivorship"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"principle":"The 2008 amendments were written to reverse a line of court decisions that had read the definition of disability narrowly, which is why the statute now instructs that it be construed in favour of broad coverage, counts remission, and ignores the effects of treatment. Naming normal cell growth as a major bodily function is what brings a cancer that causes no visible limitation inside the Act.","strengths":["Coverage is settled in regulation rather than argued case by case","Remission counts, and the effects of treatment are disregarded when deciding coverage","Leave under the Family and Medical Leave Act can be taken intermittently, which fits treatment cycles"],"limitations":["The Act does not reach employers with fewer than 15 employees","Job-protected leave requires 50 employees within 75 miles and 1,250 hours of service","Leave under the federal statute is unpaid"]},"route":"/technologies/rejuv-life-employment-rights-us/","neighbours":{"idea":[{"id":"idea-cost-financial-toxicity-screening","kind":"idea","name":"Screen every patient for money trouble the way we screen for pain","route":"/ideas/idea-cost-financial-toxicity-screening/"},{"id":"idea-acc-return-to-work-rehabilitation","kind":"idea","name":"Vocational rehabilitation integrated into cancer care so survivors can return to work","route":"/ideas/idea-acc-return-to-work-rehabilitation/"}],"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"section":[{"id":"rejuvenation","kind":"section","name":"Recovery & Rejuvenation","route":"/fronts/rejuvenation/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"technology":[{"id":"rejuv-life-employment-rights-uk","kind":"technology","name":"Employment rights with cancer in the United Kingdom","route":"/technologies/rejuv-life-employment-rights-uk/"},{"id":"financial-navigation","kind":"technology","name":"Financial toxicity and financial navigation","route":"/technologies/financial-navigation/"},{"id":"rejuv-life-return-to-work","kind":"technology","name":"Going back to work after cancer: the rates, and the programmes that change them","route":"/technologies/rejuv-life-return-to-work/"},{"id":"rejuv-life-insurance-loans-and-the-right-to-be-forgotten","kind":"technology","name":"Insurance, mortgages and the right to be forgotten","route":"/technologies/rejuv-life-insurance-loans-and-the-right-to-be-forgotten/"},{"id":"rejuv-life-money-after-treatment","kind":"technology","name":"Money after treatment: what the cost of cancer does once the treatment has finished","route":"/technologies/rejuv-life-money-after-treatment/"},{"id":"survivorship-care-plan","kind":"technology","name":"Survivorship care and late-effects surveillance","route":"/technologies/survivorship-care-plan/"}],"term":[{"id":"financial-toxicity","kind":"term","name":"Financial toxicity","route":"/terms/financial-toxicity/"},{"id":"quality-of-life","kind":"term","name":"Quality of life","route":"/terms/quality-of-life/"}],"bottleneck":[{"id":"b-survivorship","kind":"bottleneck","name":"Survivorship and late effects are neglected","route":"/bottlenecks/b-survivorship/"}]}}